A new study out of Israel found the natural immune protection developed after a COVID-19 infection does “considerably” more to ward off the delta variant than two doses of the Pfizer-BioNTech vaccine. The study found those who were once infected with COVID-19 were less likely to get the delta variant, develop symptoms or become hospitalized with a serious case of COVID than vaccinated individuals who were never infected, according to a report in the peer-reviewed journal Science. The study also found those who were previously infected with COVID and received one dose of the vaccine were even more protected against the delta variant. “This study demonstrated that natural immunity confers longer-lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant,” the study said.